101 related articles for article (PubMed ID: 10799648)
1. Shifts in the affinity distribution of one class of seven-transmembrane receptors by activation of a separate class of seven-transmembrane receptors.
Djellas Y; Antonakis K; Le Breton GC
Biochem Pharmacol; 2000 Jun; 59(12):1521-9. PubMed ID: 10799648
[TBL] [Abstract][Full Text] [Related]
2. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.
Offermanns S; Laugwitz KL; Spicher K; Schultz G
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):504-8. PubMed ID: 8290554
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
5. A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins.
Djellas Y; Antonakis K; Le Breton GC
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10944-8. PubMed ID: 9724809
[TBL] [Abstract][Full Text] [Related]
6. Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors.
Djellas Y; Manganello JM; Antonakis K; Le Breton GC
J Biol Chem; 1999 May; 274(20):14325-30. PubMed ID: 10318854
[TBL] [Abstract][Full Text] [Related]
7. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
8. Regulation of thromboxane receptor activation in human platelets.
Murray R; FitzGerald GA
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):124-8. PubMed ID: 2521385
[TBL] [Abstract][Full Text] [Related]
9. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
10. Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C.
Shock DD; He K; Wencel-Drake JD; Parise LV
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):525-30. PubMed ID: 9020890
[TBL] [Abstract][Full Text] [Related]
11. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
12. Activation of the cloned platelet thrombin receptor decreases the pertussis-toxin-dependent ADP-ribosylation of the membrane and soluble inhibitory guanine-nucleotide-binding-alpha proteins. Inhibition by the prostacyclin analog, iloprost.
Wilhelm B; Siess W
Eur J Biochem; 1993 Aug; 216(1):81-8. PubMed ID: 7689967
[TBL] [Abstract][Full Text] [Related]
13. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
D'Angelo DD; Eubank JJ; Davis MG; Dorn GW
J Biol Chem; 1996 Mar; 271(11):6233-40. PubMed ID: 8626415
[TBL] [Abstract][Full Text] [Related]
16. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
Ushikubi F; Nakamura K; Narumiya S
Mol Pharmacol; 1994 Nov; 46(5):808-16. PubMed ID: 7969066
[TBL] [Abstract][Full Text] [Related]
17. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
Lau LF; Pumiglia K; Côté YP; Feinstein MB
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
[TBL] [Abstract][Full Text] [Related]
19. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation.
Molino M; Bainton DF; Hoxie JA; Coughlin SR; Brass LF
J Biol Chem; 1997 Feb; 272(9):6011-7. PubMed ID: 9038223
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin.
Stampfuss JJ; Schrör K; Weber AA
Nat Med; 2003 Dec; 9(12):1447; author reply 1447-8. PubMed ID: 14647510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
